Collagen Glomerulopathy: COL1A2 Deficient Mouse Model
胶原蛋白肾小球病:COL1A2 缺陷小鼠模型
基本信息
- 批准号:7229786
- 负责人:
- 金额:$ 14.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-02-15 至 2009-01-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgeAge-MonthsBiological AssayBlood Urea NitrogenCOL1A2 geneChronic Kidney FailureCleaved cellCollagenCollagen GeneCollagen Type ICreatinineDepositionDiseaseDisease ProgressionEventExcretory functionExtracellular MatrixFailureFibrosisFinancial compensationFormalinGelGelatinase AGelatinase BGenotypeGlomerular Mesangial CellGoalsHistologicIn SituIn Situ HybridizationIn VitroInterstitial CollagenaseKidneyKidney DiseasesKidney FailureMatrix MetalloproteinasesMolecularMusNeutrophil CollagenaseNumbersPathogenesisPlayProductionProteinsRateRenal functionRenal glomerular diseaseResearch PersonnelReverse Transcriptase Polymerase Chain ReactionRoleSerumSeveritiesSpecificityStromelysin 1Structure of glomerular mesangiumTherapeutic InterventionWound Healingalpha 2 collagen type Icollagenase 3dayglomerulosclerosisinsightmouse modelnovelprogramsresponseurinary
项目摘要
DESCRIPTION (provided by applicant): In chronic renal disease the progressive accumulation of collagen in the glomerular mesangial matrix is a major pathological consequence, culminating in glomerulosclerosis, and renal failure. The production of excess extracellular matrix (ECM) is hypothesized to result from over compensation of the glomerular wound healing response. Though much is known concerning the initiating events leading to accumulation of the ECM, very little is known mechanistically about the role of the ECM in the pathogenesis of the glomerular mesangial cell response. Recently, we identified a novel collagen glomerulopathy in a proa2(l)collagen deficient mouse (oim), which promises to provide new insight into the regulatory role of type I collagen in the pathogenesis of glomerular disease. Oim/oim mice (homozygous null for the COL1A2 gene) are unique in that they exclusively synthesize homotrimeric type I collagen, a1(l)3, and are unable to synthesize normal heterotrimeric type I collagen, a1(l)2a2(l). Lacking a2(l) collagen chains results in deposition of homotrimeric type I collagen in the glomerular mesangium. In contrast to intact healthy kidney where no type I collagen is normally present in the glomeruli, collagen deposition and glomerular expansion are common features contributing to progressive renal disease and failure, suggesting that homotrimeric type I collagen may play an important role in the pathogenesis of glomerulosclerosis. Our long term goal is to understand the molecular mechanisms involved in the ECM deposition and pathogenesis of glomerulosclerosis in order to identify targets for therapeutic interventions. Towards this end we propose to 1) characterize the natural progression of the collagen type I glomerulopathy in oim/oim mice and to correlate pathological findings with disease progression, 2) to determine mechanistically whether type I collagen deposition in the oim/oim glomeruli is a consequence of increased collagen expression or aberrant matrix degradation, and 3) to determine if matrix metalloproteinases differentially cleave homotrimeric and heterotrimeric type I collagen.
描述(由申请人提供):在慢性肾脏疾病中,肾小球系膜基质中胶原蛋白的进行性积累是一种主要的病理后果,最终导致肾小球硬化和肾衰竭。过量细胞外基质(ECM)的产生被假设是由于肾小球伤口愈合反应的过度补偿。虽然知道很多关于启动事件导致积累的ECM,很少有人知道的机制ECM的作用,在肾小球系膜细胞反应的发病机制。最近,我们在proa 2(l)胶原蛋白缺陷小鼠(oim)中发现了一种新的胶原蛋白肾小球病,这有望为I型胶原蛋白在肾小球疾病发病机制中的调节作用提供新的见解。Oim/oim小鼠(COL 1A 2基因的纯合无效)是独特的,因为它们仅合成纯三聚体I型胶原,a1(l)3,并且不能合成正常的异三聚体I型胶原,a1(l)2a 2(l)。缺乏α 2(I)胶原蛋白链导致同源三聚体I型胶原蛋白在肾小球系膜中沉积。与正常情况下肾小球中不存在I型胶原的完整健康肾脏相反,胶原沉积和肾小球扩张是导致进行性肾病和肾衰竭的常见特征,这表明同源三聚体I型胶原可能在肾小球硬化症的发病机制中起重要作用。我们的长期目标是了解ECM沉积和肾小球硬化症发病机制的分子机制,以确定治疗干预的目标。为此,我们提出1)表征oim/oim小鼠中I型胶原肾小球病的自然进展,并将病理学发现与疾病进展相关联,2)从机理上确定oim/oim肾小球中的I型胶原沉积是否是胶原表达增加或异常基质降解的结果,和3)确定基质金属蛋白酶是否有区别地切割同源三聚体和异源三聚体I型胶原。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Carcinomas contain a matrix metalloproteinase-resistant isoform of type I collagen exerting selective support to invasion.
- DOI:10.1158/0008-5472.can-09-4057
- 发表时间:2010-06-01
- 期刊:
- 影响因子:11.2
- 作者:Makareeva E;Han S;Vera JC;Sackett DL;Holmbeck K;Phillips CL;Visse R;Nagase H;Leikin S
- 通讯作者:Leikin S
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHARLOTTE L PHILLIPS其他文献
CHARLOTTE L PHILLIPS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHARLOTTE L PHILLIPS', 18)}}的其他基金
Preclinical testing of early life anti-myostatin therapy for osteogenesis imperfecta
早期抗肌生长抑制素治疗成骨不全症的临床前测试
- 批准号:
10840238 - 财政年份:2023
- 资助金额:
$ 14.27万 - 项目类别:
Maternal Anti-myostatin (GDF8) Therapy to Enhance Offspring Musculoskeletal Health in Mouse Models of Osteogenesis Imperfecta
母体抗肌生长抑制素 (GDF8) 疗法可增强成骨不全小鼠模型后代的肌肉骨骼健康
- 批准号:
10041912 - 财政年份:2020
- 资助金额:
$ 14.27万 - 项目类别:
Maternal Anti-myostatin (GDF8) Therapy to Enhance Offspring Musculoskeletal Health in Mouse Models of Osteogenesis Imperfecta
母体抗肌生长抑制素 (GDF8) 疗法可增强成骨不全小鼠模型后代的肌肉骨骼健康
- 批准号:
10216181 - 财政年份:2020
- 资助金额:
$ 14.27万 - 项目类别:
Mechanotransduction Approach to Improve Bone Quality in Osteogenesis Imperfecta
改善成骨不全患者骨质量的力传导方法
- 批准号:
7886189 - 财政年份:2010
- 资助金额:
$ 14.27万 - 项目类别:
Mechanotransduction Approach to Improve Bone Quality in Osteogenesis Imperfecta
改善成骨不全患者骨质量的力传导方法
- 批准号:
8277100 - 财政年份:2010
- 资助金额:
$ 14.27万 - 项目类别:
Mechanotransduction Approach to Improve Bone Quality in Osteogenesis Imperfecta
改善成骨不全患者骨质量的力传导方法
- 批准号:
8076265 - 财政年份:2010
- 资助金额:
$ 14.27万 - 项目类别:
Collagen Glomerulopathy: COL1A2 Deficient Mouse Model
胶原蛋白肾小球病:COL1A2 缺陷小鼠模型
- 批准号:
7038724 - 财政年份:2006
- 资助金额:
$ 14.27万 - 项目类别:
Biomolecular Mechanics of Collagen Monomers And Fibrils
胶原单体和原纤维的生物分子力学
- 批准号:
6711818 - 财政年份:2002
- 资助金额:
$ 14.27万 - 项目类别:
Biomolecular Mechanics of Collagen Monomers And Fibrils
胶原单体和原纤维的生物分子力学
- 批准号:
6620506 - 财政年份:2002
- 资助金额:
$ 14.27万 - 项目类别:
Biomolecular Mechanics of Collagen Monomers And Fibrils
胶原单体和原纤维的生物分子力学
- 批准号:
6418426 - 财政年份:2002
- 资助金额:
$ 14.27万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 14.27万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 14.27万 - 项目类别:
Continuing Grant
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 14.27万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 14.27万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 14.27万 - 项目类别:
Fellowship
Walkability and health-related quality of life in Age-Friendly Cities (AFCs) across Japan and the Asia-Pacific
日本和亚太地区老年友好城市 (AFC) 的步行适宜性和与健康相关的生活质量
- 批准号:
24K13490 - 财政年份:2024
- 资助金额:
$ 14.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Discovering the (R)Evolution of EurAsian Steppe Metallurgy: Social and environmental impact of the Bronze Age steppes metal-driven economy
发现欧亚草原冶金的(R)演变:青铜时代草原金属驱动型经济的社会和环境影响
- 批准号:
EP/Z00022X/1 - 财政年份:2024
- 资助金额:
$ 14.27万 - 项目类别:
Research Grant
ICF: Neutrophils and cellular senescence: A vicious circle promoting age-related disease.
ICF:中性粒细胞和细胞衰老:促进与年龄相关疾病的恶性循环。
- 批准号:
MR/Y003365/1 - 财政年份:2024
- 资助金额:
$ 14.27万 - 项目类别:
Research Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 14.27万 - 项目类别:
Standard Grant
Shaping Competition in the Digital Age (SCiDA) - Principles, tools and institutions of digital regulation in the UK, Germany and the EU
塑造数字时代的竞争 (SCiDA) - 英国、德国和欧盟的数字监管原则、工具和机构
- 批准号:
AH/Y007549/1 - 财政年份:2024
- 资助金额:
$ 14.27万 - 项目类别:
Research Grant